APPLICATION
ANDA090358
TYPE
ANDA
ORIGINAL APPROVAL
2011-06-21
LATEST ACTION
2023-06-06
ROUTE
SUBCUTANEOUS
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription
Products
SUMATRIPTAN SUCCINATEPrescription
SUMATRIPTAN SUCCINATE EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) · INJECTABLE · SUBCUTANEOUS
Approval history
2023-06-06Labeling · Supplement 29 · standardAP
2019-10-29Manufacturing (CMC) · Supplement 19 · unknownAP
2019-05-22Labeling · Supplement 15 · standardAP
2016-02-09Labeling · Supplement 9 · standardAP
2016-02-09Labeling · Supplement 3 · standardAP
2016-02-09Labeling · Supplement 11 · standardAP
2014-03-14Labeling · Supplement 1AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.